| Lama Syada, PHARMD | |
|
11800 4th St, Rancho Cucamonga, CA 91730-6129 | |
| (909) 581-1700 | |
| Not Available |
| Full Name | Lama Syada |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 11800 4th St, Rancho Cucamonga, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053687517 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 49002 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lama Syada, PHARMD 11800 4th St, Rancho Cucamonga, CA 91730-6129 Ph: (909) 581-1700 | Lama Syada, PHARMD 11800 4th St, Rancho Cucamonga, CA 91730-6129 Ph: (909) 581-1700 |
News Archive
Plexxikon Inc. today announced that its acquisition by Daiichi Sankyo Company, Limited, a Japan-based global pharmaceutical company, has been successfully completed. Clearance under the Hart Scott Rodino Antitrust Improvements Act has been received. Under the terms of the deal, Plexxikon shareholders will receive $805 million up-front, with near-term milestone payments associated with the approval of PLX4032 totaling an additional $130 million.
EyeLock Inc., a market leader of iris-based identity authentication solutions, today announced that it has been named a 2015 CES Innovation Awards Honoree for myris. Products entered in this prestigious program are judged by a preeminent panel of independent industrial designers, independent engineers and members of the trade media to honor outstanding design and engineering in cutting edge consumer electronics products across 28 product categories.
Initial findings reported by the Arizona COVID-19 Genomics Union (ACGU) suggest that following Arizona's first reported case of COVID-19 in late January, the state experienced no cases that went undetected and was COVID-free until at least 11 distinct incursions occurred between mid-February and early April.
Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food and Drug Administration has approved its New Drug Application for Karbinal ER (carbinoxamine maleate) Extended-release Oral Suspension 4mg/5ml, the first sustained-release histamine receptor blocking agent indicated for the treatment of seasonal and perennial allergic rhinitis in children ages 2 and up.
Access to targeted therapies for lung cancer depends on accurate identification of patients' biomarkers through molecular testing, but survey results published today in the Journal of Thoracic Oncology suggest that many international clinicians are unaware of evidence-based guidelines that support the use of molecular testing.
› Verified 3 days ago
Dr. Greg A Simas, PHARMD MBA Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10801 6th St, Suite 120, Rancho Cucamonga, CA 91730 Phone: 951-335-3530 | |
Dr. Jason Michael Vest, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7785 Calle Casino, Rancho Cucamonga, CA 91730 Phone: 909-800-1854 | |
Sang Nhu Huynh, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11428 Kenyon Way, Rancho Cucamonga, CA 91701 Phone: 909-948-1065 | |
Wai Tai Wong, RPH, APH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8237 Rochester Ave Ste 120, Rancho Cucamonga, CA 91730 Phone: 909-980-0999 Fax: 909-980-1099 | |
Ananta Amin Akotia, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8661 Baseline Rd, Rancho Cucamonga, CA 91730 Phone: 909-989-9800 | |
Ya-wei Chung, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9713 Base Line Rd, Rancho Cucamonga, CA 91730 Phone: 909-989-8688 |